Alcohol
Volume 24, Issue 2 , Pages 63-68 , June 2001

Nicotinic receptor subtypes in human brain related to aging and dementia

Received 23 September 2000 ,Revised 4 December 2000 ,Accepted 17 December 2000.

References 

  1. Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem. 1992;58:529–541
  2. Avery EE, Baker LD, Asthana S. Potential role of muscarinic agonists in Alzheimer's disease. Drugs Aging. 1997;11:450–459
  3. Bowen D. Biochemical assessment of neurotransmitter and metabolic dysfunction and cerebral atrophy in Alzheimer's disease. In:  Katzman R editors. Biological Aspects of Alzheimer's Disease. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1983;p. 219–232
  4. Burghaus L, Schutz U, Krempel U, de Vos RA, Jansen Steur EN, Wevers A, et al. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Res Mol Brain Res. 2000;76:385–388
  5. Clementi F, Court J, Perry E. Involvement of neuronal nicotinic receptors in disease. In:  Clementi F,  Gotti C,  Fornasari D editor. Handbook of Experimental Pharmacology. vol. 144:New York: Springer; 2000;p. 751–812
  6. Court J, Perry E. Distribution of nicotinic receptors in the CNS. In:  Stone TW editors. CNS Neurotransmitters and Neuromodulators: Acetylcholine. Boca Raton, FL: CRC Press; 1995;p. 85–104
  7. Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, et al. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: α-bungarotoxin and nicotine binding in the thalamus. J Neurochem. 1999;73:1590–1597
  8. Court JA, Lloyd S, Johnson M, Griffiths M, Birdsall NJ, Piggott MA, et al. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Brain Res Dev Brain Res. 1997;101:93–105
  9. Court JA, Martin-Ruiz CM, Graham A, Perry EK. Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat. 2000;20:281–298
  10. Court JA, Martin-Ruiz CM, Piggott M, Spurden D, Griffiths M, Perry EK. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry. 2001;49:175–184
  11. Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, et al. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience. 2000;98:79–87
  12. Court JA, Piggott MA, Perry EK, Barlow RB, Perry RH. Age associated decline in high affinity nicotine binding in human brain frontal cortex does not correlate with the changes in choline acetyltransferase activity. Neurosci Res Commun. 1992;10:125–133
  13. Cummings JL, Benson DF. The role of the nucleus basalis of Meynert in dementia: review and reconsideration. Alzheimer Dis Assoc Disord. 1987;1:128–155
  14. Davies P, Feisullin S. Postmortem stability of α-bungarotoxin binding sites in mouse and human brain. Brain Res. 1981;216:449–454
  15. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease [letter]. Lancet. 1976;2:1403
  16. Flynn DD, Mash DC. Characterization of l-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal. J Neurochem. 1986;47:1948–1954
  17. Guan ZZ, Zhang X, Ravid R, Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem. 2000;74:237–243
  18. Hellström-Lindahl E, Court JA. Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging. Behav Brain Res. 2000;113:159–168
  19. Hellström-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res Mol Brain Res. 1999;66:94–103
  20. Hellström-Lindahl E, Winblad B, Nordberg A. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics. Brain Res. 1993;620:42–48
  21. Kellar K, Wonnacott S. Nicotinic cholinergic receptors in Alzheimer's disease. In:  Wonnacott S,  Russell MAH,  Stolerman IP editor. Nicotine Psychopharmacology: Molecular, Cellular, and Behavioural Aspects. Oxford: Oxford University Press; 1990;p. 341–373
  22. Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, et al. Alpha 4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem. 1999;73:1635–1640
  23. Marutle A, Warpman U, Bogdanovic N, Nordberg A. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (±)-[3H]epibatidine. Brain Res. 1998;801:143–149
  24. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992;305:673–678
  25. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124
  26. Nordberg A. Neuroreceptor changes in Alzheimer disease. Cerebrovasc Brain Metab Rev. 1992;4:303–328
  27. Nordberg A, Adolfsson R, Marcusson J, Winblad B. Cholinergic receptors in the hippocampus in normal aging and dementia of Alzheimer type. In:  Giacobini E,  Filogam G,  Giacobini F,  Vernadahis A editor. The Aging Brain: Cellular and Molecular Mechanisms of Aging in the Nervous System. vol. 20:New York: Raven Press; 1982;p. 231–245
  28. Nordberg A, Lundqvist H, Hartvig P, Lilja A, Långström B. Kinetic analysis of regional (S)(−)11C-nicotine binding in normal and Alzheimer brains — in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord. 1995;9:21–27
  29. Nordberg A, Winblad B. Brain nicotinic and muscarinic receptors in normal aging and dementia. In:  Fisher A,  Hanin I,  Lachman C editor. Alzheimer's and Parkinson's Diseases: Strategies for Research and Development. New York: Plenum Press; 1986;p. 95–108
  30. Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol. 2000;61:75–111
  31. Perry E, Court J, Piggott M, Perry R. Cholinergic component of dementia and aging. In:  Huppert FA,  Brayne C,  O'Connor DW editor. Dementia and Normal Aging. Cambridge: Cambridge University Press; 1994;p. 437–460
  32. Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, et al. Nicotinic receptor subtypes in human brain aging, Alzheimer and Lewy body diseases. Eur J Pharmacol. 2000;393:215–222
  33. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, et al. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 1995;64:385–395
  34. Perry EK, Smith CJ, Atack JR, Candy JM, Johnson M, Perry RH. Neocortical cholinergic enzyme and receptor activities in the human fetal brain. J Neurochem. 1986;47:1262–1269
  35. Perry EK, Smith CJ, Court JA, Perry RH. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm Park Dis Dement Sect. 1990;2:149–158
  36. Perry EK, Smith CJ, Perry RH, Johnson M, Fairbairn AF. Nicotine [3H-nicotine] receptor binding in human brain: characterization and involvement in cholinergic neuropathology. Neurosci Res Commun. 1989;5:117–124
  37. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 1990;95:119–139
  38. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain. 1999;122(Pt 8):1449–1468
  39. Rinne JO, Myllykylä T, Lönnberg P, Marjamäki P. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res. 1991;547:167–170
  40. Sabbagh MN, Reid RT, Corey-Bloom J, Rao TS, Hansen LA, Alford M, et al. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. J Neural Transm. 1998;105:709–717
  41. Schroder H, Wevers A. Nicotinic acetylcholine receptors in Alzheimer's disease. Alz Dis Rev. 1998;3:20–27
  42. Schroder H, Zilles K, Maelicke A, Hajos F. Immunohisto- and cytochemical localization of cortical nicotinic cholinoceptors in rat and man. Brain Res. 1989;502:287–295
  43. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J Neurochem. 1986;46:288–293
  44. Sparks DL, Beach TG, Lukas RJ. Immunohistochemical localization of nicotinic β2 and α4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations. Neurosci Lett. 1998;256:151–154
  45. Sugaya K, Giacobini E, Chiappinelli VA. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J Neurosci Res. 1990;27:349–359
  46. Terzano S, Court JA, Fornasari D, Griffiths M, Spurden DP, Lloyd S, et al. Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. Brain Res Mol Brain Res. 1998;63:72–78
  47. Tiraboschi P, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, et al. Cholinergic dysfunction in diseases with Lewy bodies. Neurology. 2000;54:407–411
  48. Tohgi H, Utsugisawa K, Yoshimura M, Nagane Y, Mihara M. Age-related changes in nicotinic acetylcholine receptor subunits α4 and β2 messenger RNA expression in postmortem human frontal cortex and hippocampus. Neurosci Lett. 1998;245:139–142
  49. Tohgi H, Utsugisawa K, Yoshimura M, Nagane Y, Mihara M. Alterations with aging and ischemia in nicotinic acetylcholine receptor subunits α4 and β2 messenger RNA expression in postmortem human putamen. Implications for susceptibility to parkinsonism. Brain Res. 1998;791:186–190
  50. Utsugisawa K, Nagane Y, Tohgi H, Yoshimura M, Ohba H, Genda Y. Changes with aging and ischemia in nicotinic acetylcholine receptor subunit α7 mRNA expression in postmortem human frontal cortex and putamen. Neurosci Lett. 1999;270:145–148
  51. Wevers A, Monteggia L, Nowacki S, Bloch W, Schütz U, Lindstrom J, et al. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur J Neurosci. 1999;11:2551–2565
  52. Xuereb JH, Perry EK, Candy JM, Bonham JR, Perry RH, Marshall E. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. J Neurol Sci. 1990;99:185–197

PII: S0741-8329(01)00130-6

Alcohol
Volume 24, Issue 2 , Pages 63-68 , June 2001

Article Tools

* Image Usage & Resolution